(DXT40) Effect of the S1P1/5 Receptor Modulator Ozanimod on Cognitive Processing Speed in Subjects with Relapsing Multiple Sclerosis: Design of the ENLIGHTEN Study. JV Riolo, L Yang, T Rano, R Zivadinov, LB Krupp, J Calkwood, O Stuve, ... International Journal of MS Care 22, 2020 | 1 | 2020 |
1.1 Conscientiousness and Cognitive Decline T Fuchs, C Wojcik, GE Wilding, J Pol, MG Dwyer, B Weinstock-Guttman, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
1.2 Conscientiousness and Brain Atrophy TA Fuchs, RHB Benedict, G Wilding, C Wojcik, D Jakimovski, N Bergsland, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
103 Exploring the influence of quantitative magnetic resonance imaging on decision-making in multiple sclerosis clinical practice HN Beadnall, L Ly, C Wang, T Billiet, A Ribbens, W Van Hecke, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (6), A41-A41, 2018 | 2 | 2018 |
2.1 Longitudinal Conscientiousness Decline S Roy, A Drake, TA Fuchs, MG Dwyer, R Zivadinov, BP Chapman, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
2.2 Brain Connectome and Reduced Conscientiousness T Fuchs, M Dwyer, A Kuceyeski, S Choudhery, K Carolus, X Li, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
2329 Innovative comparative study assessing the effect of siponimod on reactive microglia/astrocytes in patients with secondary progressive multiple sclerosis: study design R Walker, R Zivadinov, B Weinstock-Guttman, R Benedict, MG Dwyer, ... BMJ Neurology Open 4 (Suppl 1), 2022 | | 2022 |
24-Month Efficacy and Safety of Glatiramer Acetate 40mg/1mL 3-Times Weekly: Open-label Extension Study of the GALA Trial in Subjects With Relapsing-Remitting Multiple Sclerosis … O Khan, P Rieckmann, A Boyko, K Selmaj, H Barkay, S Kolodny, ... Neurology 82 (10_supplement), S31. 003, 2014 | 5 | 2014 |
3.1 Functional Brain Connectome and Cognition F Lin, R Zivadinov, J Hagemeier, B Weinstock-Guttman, C Vaughn, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
3.2 Brain Connectome and Cognitive Reserve TA Fuchs, RHB Benedict, A Bartnik, S Choudhery, X Li, M Mallory, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
3.3 Conscientiousness, Cognitive Reserve, and Response to Cognitive Intervention TA Fuchs, S Ziccardi, MG Dwyer, LE Charvet, A Bartnik, R Campbell, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
3.4 Brain Connectome, Cognitive Reserve, and Response to Cognitive Intervention TA Fuchs, S Ziccardi, RHB Benedict, A Bartnik, LE Charvet, D Oship, ... Conscientiousness, Cognitive Reserve, and the Human Brain Connectome in …, 2019 | | 2019 |
3D DIR: 3D Double Inversion Recovery in Multiple Sclerosis P Polak, R Zivadinov, G Poloni | | |
3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis P Polak, C Magnano, R Zivadinov, G Poloni Magnetic Resonance in Medicine 68 (3), 874-881, 2012 | 33 | 2012 |
3T predicts better Clinical and demographic outcomes in patients with multiple sclerosis than 1.5 T. A preliminary case-control study C Di Perri, M Dwyer, JL Cox, K Hashmi, D Wack, S Hussein, M Stosic, ... MULTIPLE SCLEROSIS JOURNAL 14, S102-S102, 2008 | | 2008 |
5-year conversion to clinically diagnosed depression in people with multiple sclerosis is predicted by baseline tract damage in fronto-parietal network K Ashton, T Fuchs, D Oship, R Zivadinov, B Weinstock-Guttman, ... MULTIPLE SCLEROSIS JOURNAL 25, 427-427, 2019 | 1 | 2019 |
9.4 Tesla 1H-MRS of Glutamate and GABA in a 3.6 cubic-mm volume using an optimized UTE-STEAM sequence N Bertolino, P Polak, M Preda, R Zivadinov, F Schweser Proc Intl Soc Mag Reson Med, Singapore 24, 2383, 2016 | 2 | 2016 |
9.4 Tesla in vivo quantitative susceptibility mapping (QSM) detects thalamic calcium influx associated with repeated mild traumatic brain injury (mTBI) F Schweser, A Poulsen, D Shah, N Bertolino, M Preda, J Kyyriäinen, ... Proceedings of the Annual Meeting and Exhibition of the International …, 2017 | 1 | 2017 |
A 3-year, longitudinal MRI study in pediatric patients with MS, CIS, ADEM and OND M Varosanec, B Weinstock-Guttman, AE Yeh, MJ Karpinski, ... MULTIPLE SCLEROSIS JOURNAL 20, 398-398, 2014 | | 2014 |
A case-control study of cancer risk among MS patients treated with methotrexate N Garg, R Zivadinov, DL Cookfair, A Supala, R Wehbeh, DP Singh, ... NEUROLOGY 66 (5), A228-A228, 2006 | | 2006 |